Neurobiological Technologies, Inc.
NTII
$0.00
$0.000.00%
OTC PK
| 12/17/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | 12/31/2008 | |
|---|---|---|---|---|---|
| Net Income | 18.67M | 11.29M | 3.12M | -14.49M | -19.12M |
| Total Depreciation and Amortization | 51.00K | 97.00K | 132.00K | 163.00K | 191.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | 0.00 | 0.00 |
| Total Other Non-Cash Items | 1.18M | 1.74M | 1.93M | 1.10M | 2.47M |
| Change in Net Operating Assets | -23.59M | -24.19M | -21.62M | -3.02M | -1.16M |
| Cash from Operations | -3.69M | -11.06M | -16.43M | -16.25M | -17.62M |
| Capital Expenditure | 0.00 | 0.00 | -2.00K | -2.00K | -13.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 14.00K | 0.00 | 1.00K | -2.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 24.97M | -5.49M | -3.28M | -7.22M | -7.71M |
| Cash from Investing | 24.97M | -5.48M | -3.28M | -7.22M | -7.73M |
| Total Debt Issued | -- | -- | -- | -5.99M | -5.99M |
| Total Debt Repaid | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Common Stock | 59.00K | 1.00K | 1.00K | 5.94M | 5.94M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -247.00K | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -25.13M | -- | -- | -- | -- |
| Cash from Financing | -25.32M | 1.00K | 1.00K | -53.00K | -52.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.04M | -16.54M | -19.71M | -23.52M | -25.40M |